Immunovant, Inc.
US ˙ NasdaqGS ˙ US45258J1025

SecurityIMVT / Immunovant, Inc.
InstitutionAlpine Global Management, LLC
Latest Disclosed Ownership2,636,925 shares
Latest Disclosed Value $ 65,501,217
Alpine Global Management, LLC reports 0.39% increase in ownership of IMVT / Immunovant, Inc.

On May 15, 2026 - Alpine Global Management, LLC filed a 13F-HR form disclosing ownership of 2,636,925 shares of Immunovant, Inc. (US:IMVT) valued at $65,501,217 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on February 26, 2026 disclosing 2,626,692 shares of Immunovant, Inc.. This represents a change in shares of 0.39% during the quarter. The current value of the position is $82,034,737 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IMMUNOVANT COM 45258J102 2,636,925 10,233 0.39 65,501 -1.90 9.8065
2026-02-26 2025-12-31 13F/A-1 IMMUNOVANT COM 45258J102 2,626,692 -128,039 -4.65 66,771 50.36 14.3931
2026-02-17 2025-12-31 13F IMMUNOVANT COM 45258J102 2,627,692 -127,039 66,771 11.3612
2025-11-21 2025-09-30 13F/A-1 IMMUNOVANT COM 45258J102 2,754,731 128,039 4.87 44,406 5.66 9.0015
2025-11-14 2025-09-30 13F IMMUNOVANT COM 45258J102 2,754,731 128,039 44,406 7.6464
2025-08-14 2025-06-30 13F IMMUNOVANT COM 45258J102 2,626,692 0 0.00 42,027 -6.38 9.4735
2025-05-15 2025-03-31 13F IMMUNOVANT COM 45258J102 2,626,692 467,788 21.67 44,890 -16.06 11.8841
2025-02-18 2024-12-31 13F/A-1 IMMUNOVANT COM 45258J102 2,158,904 276,200 14.67 53,476 -0.37 15.7521
2025-02-14 2024-12-31 13F IMMUNOVANT COM 45258J102 2,158,904 276,200 53,476 12.5543
2024-11-14 2024-09-30 13F IMMUNOVANT COM 45258J102 1,882,704 -25,000 -1.31 53,676 6.58 12.9934
2024-08-14 2024-06-30 13F IMMUNOVANT COM 45258J102 1,907,704 25,000 1.33 50,363 -17.21 8.7581
2024-08-06 2024-03-31 13F/A-1 IMMUNOVANT COM 45258J102 1,882,704 484,332 34.64 60,830 3.25 11.7826
2024-05-15 2024-03-31 13F IMMUNOVANT COM 45258J102 1,882,704 484,332 60,830 15.2943
2024-08-06 2023-12-31 13F/A-1 IMMUNOVANT COM 45258J102 1,398,372 145,898 11.65 58,913 22.53 16.0913
2024-02-12 2023-12-31 13F IMMUNOVANT COM 45258J102 1,398,372 145,898 58,913 18.8374
2024-08-06 2023-09-30 13F/A-1 IMMUNOVANT COM 45258J102 1,252,474 -187,070 -13.00 48,082 76.07 11.0890
2023-11-14 2023-09-30 13F IMMUNOVANT COM 45258J102 1,252,474 -187,070 48 12.1516
2024-08-06 2023-06-30 13F/A-1 IMMUNOVANT COM 45258J102 1,439,544 0 0.00 27,308 22.31 7.5162
2023-08-14 2023-06-30 13F IMMUNOVANT COM 45258J102 1,439,544 0 27 8.2906
2023-11-21 2023-03-31 13F/A-1 IMMUNOVANT COM 45258J102 1,439,544 -60,456 -4.03 22,327 -16.14 8.6737
2023-05-15 2023-03-31 13F IMMUNOVANT COM 45258J102 1,439,544 -60,456 22 8.6737
2023-02-14 2022-12-31 13F IMMUNOVANT COM 45258J102 1,500,000 -2,848,017 -65.50 26,625 9.74 8.8517
2022-11-14 2022-09-30 13F IMMUNOVANT COM 45258J102 4,348,017 -100,000 -2.25 24,262 39.86 5.6772
2022-11-03 2022-06-30 13F/A-1 IMMUNOVANT COM 45258J102 4,448,017 586,228 15.18 17,347 -18.47 4.9590
2022-08-15 2022-06-30 13F IMMUNOVANT COM 45258J102 4,448,017 586,228 17,347 4.9656
2022-05-16 2022-03-31 13F/A-1 IMMUNOVANT COM 45258J102 3,861,789 854,789 28.43 21,278 -16.95 4.8306
2022-05-13 2022-03-31 13F IMMUNOVANT COM 45258J102 3,861,789 854,789 21,278 5.8633
2022-02-14 2021-12-31 13F IMMUNOVANT COM 45258J102 3,007,000 6,800 0.23 25,620 -1.73 3.7659
2021-11-12 2021-09-30 13F/A-1 IMMUNOVANT COM 45258J102 3,000,200 1,000,200 50.01 26,072 23.33 5.9189
2021-11-12 2021-09-30 13F IMMUNOVANT COM 45258J102 3,000,000 1,000,000 25,980 2.5294
2021-08-13 2021-06-30 13F IMMUNOVANT COM 45258J102 2,000,000 903,022 82.32 21,140 20.14 2.8789
2021-05-13 2021-03-31 13F IMMUNOVANT COM 45258J102 1,096,978 1,096,978 17,596 1.6869
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.